Janux Therapeutics Ownership | Who Owns Janux Therapeutics?
Janux Therapeutics Ownership Summary
Janux Therapeutics is owned by 97.49% institutional investors, 1.49% insiders, and 1.01% retail investors. Ra capital management is the largest institutional shareholder, holding 17.86% of JANX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.67% of its assets in Janux Therapeutics shares.
JANX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Janux Therapeutics | 97.49% | 1.49% | 1.01% |
| Sector | Healthcare Stocks | 50.51% | 12.37% | 37.12% |
| Industry | Biotech Stocks | 48.95% | 12.07% | 38.98% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 11.19M | 17.86% | $171.87M |
| Blackrock funding, inc. /de | 6.13M | 9.79% | $94.23M |
| Janus henderson group | 4.20M | 6.77% | $58.28M |
| Prosight management, lp | 3.80M | 6.07% | $58.44M |
| State street | 3.00M | 4.80% | $46.16M |
| Blackrock | 2.34M | 4.78% | $98.19M |
| Paradigm biocapital advisors lp | 2.92M | 4.72% | $71.37M |
| Vanguard group | 2.91M | 4.69% | $40.11M |
| Fmr | 2.41M | 3.85% | $37.06M |
| Federated hermes | 2.35M | 3.75% | $36.14M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Prosight management, lp | 3.80M | 10.07% | $58.44M |
| Avalon ventures management | 53.30K | 9.17% | $1.30M |
| Bioimpact capital | 614.28K | 2.46% | $15.01M |
| Paradigm biocapital advisors lp | 2.92M | 2.03% | $71.37M |
| Ra capital management | 11.19M | 1.49% | $171.87M |
| Lion point capital, lp | 19.00K | 1.40% | $291.84K |
| Rangeley capital | 97.98K | 1.37% | $1.50M |
| Bml capital management | 154.96K | 1.35% | $2.38M |
| Nano cap new millennium growth fund l p | 56.00K | 0.66% | $860.16K |
| Tcg crossover management | 1.79M | 0.66% | $27.49M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Federated hermes | 2.35M | 0.05% | 2.30M |
| Two sigma investments, lp | 1.21M | 0.01% | 1.09M |
| Holocene advisors, lp | 1.02M | 0.17% | 1.02M |
| D. e. shaw | 1.10M | 0.01% | 998.11K |
| Citadel advisors | 1.20M | 0.00% | 848.56K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | - | - | -1.47M |
| Deep track capital, lp | - | - | -1.19M |
| Janus henderson group | 4.20M | 0.03% | -1.15M |
| Logos global management lp | - | - | -1.00M |
| Rtw investments, lp | - | - | -1.00M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Holocene advisors, lp | 1.02M | 0.17% | 1.02M | $54.35M |
| Sixth street partners management company | 369.19K | 0.00% | 369.19K | $5.67M |
| Panagora asset management | 269.11K | 0.01% | 269.11K | $4.13M |
| Thrivent financial for lutherans | 115.03K | 0.00% | 115.03K | $1.77M |
| Aqr capital management | 108.08K | 0.00% | 108.08K | $1.66M |
Sold Out
| Holder | Change |
|---|---|
| Bayforest capital | -3.00 |
| Massmutual trust co fsb/adv | -6.00 |
| Corecap advisors | -9.00 |
| Stephens consulting | -15.00 |
| Capital performance advisors llp | -17.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 202 | 1.00% | 61,095,092 | 2.53% | 97 | 1.08% | 118 | 4.42% | 47 | -9.62% |
| Mar 31, 2026 | 117 | -37.77% | 14,603,619 | -76.52% | 23 | 0.23% | 73 | -35.96% | 23 | -43.90% |
| Dec 31, 2025 | 139 | -23.20% | 36,407,138 | -44.13% | 58 | 0.53% | 83 | 2.47% | 29 | -53.23% |
| Sep 30, 2025 | 172 | -1.71% | 64,553,591 | 1.68% | 104 | 0.99% | 79 | -14.13% | 59 | 15.69% |
| Jun 30, 2025 | 180 | -6.25% | 65,438,049 | -1.58% | 105 | 0.91% | 93 | -21.19% | 53 | 23.26% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 2.20M | 3.67% | 2.89K |
| Fidelity Growth Compy Commingled Pl O | 1.65M | 3.16% | 20.65K |
| State Street® SPDR® S&P® Biotech ETF | 1.90M | 3.11% | 4.36K |
| Fidelity Growth Company Fund | 1.56M | 2.60% | -9.34K |
| Federated Hermes MDT Small Cap Core IS | 1.28M | 2.11% | 1.28M |
| Federated Hermes MDT SCC Institutional | 1.28M | 2.10% | 1.28M |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.26M | 2.07% | 38.00K |
| Vanguard Total Stock Mkt Idx Inv | 1.26M | 2.07% | 38.00K |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.26M | 2.07% | - |
| iShares Russell 2000 ETF | 1.10M | 1.81% | -19.58K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 02, 2026 | Doyle Janeen Noel | Chief Corp. & Bus. Dev. Ofcr | Sell | $56.94K |
| May 11, 2026 | Dobek Maria | Vice President, Accounting | Sell | $28.88K |
| Jan 02, 2026 | Meyer Andrew Hollman | Chief Business Officer | Sell | $25.80K |
| Jan 02, 2026 | DiRaimondo Thomas | Chief Scientific Officer | Sell | $34.39K |
| Jan 02, 2026 | Campbell David Alan | President and CEO | Sell | $110.83K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | - |
| 2026 Q2 | - | 2 |
| 2026 Q1 | - | 6 |
| 2025 Q4 | - | 4 |
| 2025 Q2 | - | 3 |
JANX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools